The prophylactic effect of co-enzyme Q10 versus placebo on contrast-induced nephropathy in patients with diabetes mellitus type II
Phase 2
Recruiting
- Conditions
- Diabetes mellitus with nephropathy.Diabetes mellitus due to underlying condition with diabetic nephropathyE08.21
- Registration Number
- IRCT20120215009014N337
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
Age of 18 to 65 years,
Diabetes mellitus type II for at least one year,
Need for CT scan with contrast material,
Microalbuminuria or macroalbuminuria
Exclusion Criteria
Pregnancy or breastfeeding,
Receiving contrast material last week,
Taking antioxidants last week,
Kidney activity instability,
Sensitivity to iodinated contrast agents
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum creatinine. Timepoint: Daily before the intervention and 7 days after that. Method of measurement: By laboratory test.
- Secondary Outcome Measures
Name Time Method